May - 2019
| Previous Next | Showing Journal 2 of 9 |
 Early Neuromuscular Blockade in the Acute Respiratory Distress SyndromeThe National Heart, Lung, and Blood Institute PETAL Clinical Trials Network New Eng J Med, 2019, online first May 2019 This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register |
May |
Previous Comments
| Results of this trial are contrary to the results of the previously reported mortality benefit in ARDS similar trial published in 2010;hence it supports practice of avoiding NMB altogether if possible,which in turn could minimise the complications associated with their use!!! | |
| FREOKUMAR-04 Dec, 2019 03:11:24 PM | |
Comment
In 2010 the Papazian ACURASYS Study https://www.crit-iq.com/index.php/Library/Review/383/neuromuscular-blocker-ARDS-ventilation-protectivereported in...